Company · CIK 0000811641 · SIC 2835 — In Vitro & In Vivo Diagnostic Substances · Nasdaq
IMMUCELL CORP /DE/ · ICCC
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 18, 2026 PForm 4 → | Jun 22, 8:33 am EDT | Boekhorst Paul Francis Olivier tePresident and CEO, Director | 8,000 | $9.50 | $75,960 | 17,785 | +81.8% |
Reported at this company — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.